Data / Drug companies / Clonidine hydrochloride
Clonidine hydrochloride: 45 companies and 145 products in the FDA NDC directory
Clonidine hydrochloride is listed in the FDA National Drug Code Directory by 45 companies, with 145 products in commercial distribution. 142 of the products (97.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; injection, solution, and the newest product started marketing on September 22, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 45
- Products
- 145
- Generic (ANDA) products
- 142 (97.9%)
- Application numbers
- 20
- Routes
- Oral, Intravenous, Epidural
- Brand names
- Duraclon, Onyda XR, Qlonilik
- openFDA record search
- api.fda.gov
Companies that list clonidine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 11 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Remedyrepack Inc. | 9 | tablet | Generic drugs (ANDA) | July 1, 2025 |
| A-S Medication Solutions | 8 | tablet | Generic drugs (ANDA) | June 2, 2021 |
| Bryant Ranch Prepack | 7 | tablet | Generic drugs (ANDA) | July 1, 2020 |
| Bryant Ranch Prepack | 7 | tablet; tablet, extended release | Generic drugs (ANDA) | June 2, 2021 |
| NuCare Pharmaceuticals,Inc. | 7 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Northwind Health Company, LLC | 6 | tablet | Generic drugs (ANDA) | December 6, 2022 |
| Actavis Pharma, Inc. | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | June 17, 2015 |
| Alembic Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | September 22, 2026 |
| Alembic Pharmaceuticals Limited | 4 | tablet | Generic drugs (ANDA) | September 22, 2026 |
| Asclemed USA, Inc. | 4 | tablet | Generic drugs (ANDA) | June 1, 2017 |
| BluePoint Laboratories | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | August 24, 2023 |
| Preferred Pharmaceuticals Inc. | 4 | tablet | Generic drugs (ANDA) | July 26, 2023 |
| Proficient Rx LP | 4 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Solco Healthcare US, LLC | 4 | tablet; tablet, extended release | Generic drugs (ANDA) | January 5, 2023 |
| TruPharma, LLC | 4 | tablet | Generic drugs (ANDA) | April 13, 2026 |
| American Health Packaging | 3 | tablet; tablet, extended release | Generic drugs (ANDA) | July 30, 2020 |
| Asclemed USA Inc. | 3 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Aurobindo Pharma Limited | 3 | tablet | Generic drugs (ANDA) | June 2, 2021 |
| AvPAK | 3 | tablet | Generic drugs (ANDA) | May 30, 2023 |
| Cardinal Health 107, LLC | 3 | tablet | Generic drugs (ANDA) | October 9, 2025 |
| Coupler LLC | 3 | tablet | Generic drugs (ANDA) | August 7, 2026 |
| Method Pharmaceuticals, LLC | 3 | tablet | Generic drugs (ANDA) | July 1, 2020 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 3 | tablet | Generic drugs (ANDA) | January 3, 1995 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, solution | Generic drugs (ANDA) | January 1, 2011 |
| Major Pharmaceuticals | 2 | tablet | Generic drugs (ANDA) | November 21, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | September 21, 2009 |
| Redpharm Drug | 2 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| St. Mary's Medical Park Pharmacy | 2 | tablet | Generic drugs (ANDA) | April 15, 2025 |
| Unit Dose Solutions, Inc. | 2 | tablet | Generic drugs (ANDA) | June 17, 2026 |
| Verityrx, LLC | 2 | tablet | Generic drugs (ANDA) | December 24, 2020 |
| Ajanta Pharma USA Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | November 21, 2017 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | January 3, 1995 |
| Aphena Pharma Solutions - Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | June 1, 2017 |
| CMP Pharma, Inc. | 1 | solution | New drug applications (NDA) | August 28, 2026 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | April 4, 2019 |
| Lupin Pharmaceuticals, Inc. | 1 | tablet, extended release | Generic drugs (ANDA) | February 7, 2018 |
| Mylan Institutional LLC | 1 | injection, solution | New drug applications (NDA) | January 26, 1997 |
| NextWave Pharmaceuticals, Inc | 1 | suspension, extended release | New drug applications (NDA) | August 13, 2024 |
| NuCare Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | September 21, 2009 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | May 3, 2016 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | September 4, 1987 |
| Somerset Therapeutics, LLC | 1 | tablet, extended release | Generic drugs (ANDA) | March 4, 2025 |
| Xiamen LP Pharmaceutical Co., Ltd. | 1 | tablet, extended release | Generic drugs (ANDA) | December 1, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 131 | 90.3% |
| Tablet, extended release | 9 | 6.2% |
| Injection, solution | 3 | 2.1% |
| Suspension, extended release | 1 | 0.7% |
| Solution | 1 | 0.7% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 142 | 97.9% |
| New drug applications (NDA) | 3 | 2.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Central alpha-2 Adrenergic Agonist | 145 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.